| Form type | Sec Links | Description | Filing date | Reporting date |
|---|
Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | May 1, 2025 | Mar 31, 2025 |
| 8-K | Report | Data | 8-K | Apr 24, 2025 | Apr 24, 2025 |
| 8-K | Report | Data | 8-K | Mar 27, 2025 | Mar 27, 2025 |
| 8-K | Report | Data | 8-K | Mar 4, 2025 | Mar 2, 2025 |
| 10-K | Report | Data | 10-K | Mar 3, 2025 | Dec 31, 2024 |
| 6-K | Report | TOTAL VOTING RIGHTS | Mar 3, 2025 | Mar 3, 2025 |
| 6-K | Report | DIRECTOR/PDMR SHAREHOLDING | Feb 28, 2025 | Feb 28, 2025 |
| 6-K | Report | DIRECTOR/PDMR SHAREHOLDING | Feb 28, 2025 | Feb 28, 2025 |
| 6-K | Report | HOLDING(S) IN COMPANY | Feb 28, 2025 | Feb 28, 2025 |
| 6-K | Report | DIRECTOR/PDMR SHAREHOLDING | Feb 27, 2025 | Feb 27, 2025 |
| 6-K | Report | DIRECTOR/PDMR SHAREHOLDING | Feb 27, 2025 | Feb 27, 2025 |
| 6-K | Report | JOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICER | Feb 27, 2025 | Feb 27, 2025 |
| 6-K | Report | HOLDING(S) IN COMPANY | Feb 25, 2025 | Feb 25, 2025 |
| 6-K | Report | FDA APPROVAL OF SUBLOCADE LABEL CHANGES | Feb 24, 2025 | Feb 24, 2025 |
| 6-K/A | Report | 6-K/A | Feb 20, 2025 | Dec 31, 2024 |
| 6-K | Report | 6-K | Feb 20, 2025 | Dec 31, 2024 |
| 6-K | Report | DELAYED FDA APPROVAL OF SUBLOCADE LABEL CHANGES | Feb 12, 2025 | Feb 12, 2025 |
| 6-K | Report | NOTICE OF RESULTS | Feb 4, 2025 | Feb 4, 2025 |
| 6-K | Report | COMPLETION OF SHARE REPURCHASE PROGRAM | Feb 4, 2025 | Feb 4, 2025 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Feb 4, 2025 | Feb 4, 2025 |
| 6-K | Report | TOTAL VOTING RIGHTS | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Report | APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Report | DR. DAVID WHEADON APPOINTED CHAIR OF THE BOARD | Jan 28, 2025 | Jan 28, 2025 |
| 6-K | Report | HOLDING(S) IN COMPANY | Jan 28, 2025 | Jan 28, 2025 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Jan 28, 2025 | Jan 28, 2025 |
| 6-K | Report | HOLDING(S) IN COMPANY | Jan 27, 2025 | Jan 27, 2025 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Jan 21, 2025 | Jan 21, 2025 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Jan 14, 2025 | Jan 14, 2025 |
| 6-K | Report | INDIVIOR PROVIDES HISTORICAL FINANCIALS IN US GAAP | Jan 10, 2025 | Jan 10, 2025 |
| 6-K | Report | HOLDING(S) IN COMPANY | Jan 7, 2025 | Jan 7, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Jan 7, 2025 | Jan 7, 2024 |
| 6-K | Report | TOTAL VOTING RIGHTS | Jan 2, 2025 | Jan 2, 2025 |
| 6-K | Report | HOLDING(S) IN COMPANY | Dec 31, 2024 | Dec 31, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Dec 31, 2024 | Dec 31, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Dec 26, 2024 | Dec 26, 2024 |
| 6-K | Report | DIRECTOR/PDMR SHAREHOLDING | Dec 23, 2024 | Dec 23, 2024 |
| 6-K | Report | INDIVIOR ANNOUNCES CHANGES TO BOARD OF DIRECTORS | Dec 17, 2024 | Dec 17, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Dec 17, 2024 | Dec 17, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Dec 10, 2024 | Dec 10, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Dec 3, 2024 | Dec 3, 2024 |
| 6-K | Report | TOTAL VOTING RIGHTS | Dec 2, 2024 | Dec 2, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Nov 26, 2024 | Nov 26, 2024 |
| 6-K | Report | INDIVIOR TO PARTICIPATE IN UPCOMING INVESTOR EVENT | Nov 22, 2024 | Nov 22, 2024 |
| 6-K | Report | TRANSACTION IN OWN SHARES | Nov 19, 2024 | Nov 19, 2024 |
| 6-K | Report | HOLDING(S) IN COMPANY | Nov 18, 2024 | Nov 18, 2024 |
| SC 13G | Report | Nov 15, 2024 | ||
| 6-K | Report | DIRECTOR DECLARATION | Nov 15, 2024 | Nov 15, 2024 |
| SC 13G/A | Report | Nov 14, 2024 | ||
| 6-K | Report | TRANSACTION IN OWN SHARES | Nov 12, 2024 | Nov 12, 2024 |
| 6-K | Report | HOLDING(S) IN COMPANY | Nov 12, 2024 | Nov 12, 2024 |